Skip to content
Trial Eligibility
Menu

Changes in Inhibition and Valuation After Eating

NCT05995496

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

An impaired ability to exert control has been implicated in bulimia nervosa (BN), but this impairment may not represent a stable trait or be the most effective focus for treatment. This project aims to understand how predictions and value-based decisions about control may be abnormally influenced by eating in individuals with BN, thereby maintaining cycles of binge eating, purging, and restriction.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Bulimia Nervosa

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 45 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
Icahn School of Medicine at Mount Sinai
Last updated on ClinicalTrials.gov
February 17, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Center of Excellence in Eating and Weight Disorders at the Icahn School of Medicine at Mount Sinai · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.